Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Raynaud Phenomenon Clinical Trials
Raynaud Phenomenon clinical trials are recruiting across 17 cities. Here are the cities with the most active studies:
Raynaud Phenomenon Trial Phases
5 research organizations are sponsoring raynaud phenomenon trials.
About Raynaud Phenomenon
Raynaud phenomenon is a condition causing reduced blood flow to fingers and toes in response to cold or stress, causing color changes and numbness. It can occur alone (primary) or with an underlying disease (secondary). Treatment includes keeping warm, calcium channel blockers, and avoiding triggers.
Clinical trials are advancing new treatments for raynaud phenomenon. Currently, 5 studies are recruiting a combined 526 participants across the United States. Research is being conducted by 5 organizations including Vesalio, Robyn T. Domsic, MD, MPH, University of California, San Diego and 2 others.
2026 Raynaud Phenomenon Research Landscape
As of July 2026, the raynaud phenomenon clinical trial landscape includes 5 actively recruiting studies across 17 cities in the United States. These studies are collectively seeking 526 participants, with an average enrollment target of 105 per study.
The research spans multiple phases of development: 2 studies are in NA, 2 studies are in PHASE4.
Research is being led by 5 different organizations, including Vesalio, Robyn T. Domsic, MD, MPH, University of California, San Diego, Emory University, Brigham and Women's Hospital.
Geographically, raynaud phenomenon trials are most concentrated in Burbank, California (1 trial); Walnut Creek, California (1 trial); New Haven, Connecticut (1 trial); Miami, Florida (1 trial); Marietta, Georgia (1 trial) and 7 other cities.
Featured Raynaud Phenomenon Studies
Highlighted recruiting studies for raynaud phenomenon, selected by enrollment size and research scope.
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifically, we will evaluate if the Apollo Neuro device may improve the two specific symptoms highest ranked by patients as affecting qualify of life (fatigue, Raynaud phenomenon) as co-primary outcomes.
Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage
Vasospasm is a common complication after rupture of intracranial aneurysms causing devastating neurologic deficits and death. Vasospasm has been directly associated with the amount of subarachnoid blood inside the basal cisterns. Prior literature has attempted to refine treatment of ruptured intracranial aneurysms but does not have clear guidelines on the optimal method to drain subarachnoid blood...
Frequently Asked Questions About Raynaud Phenomenon Clinical Trials
Are there raynaud phenomenon clinical trials near me?
Yes, there are 5 raynaud phenomenon clinical trials currently recruiting across 17+ cities in the United States, including Burbank, California; Walnut Creek, California; New Haven, Connecticut. Browse the studies above to find one at a location convenient for you.
How do I join a raynaud phenomenon clinical trial?
To join a raynaud phenomenon clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are raynaud phenomenon clinical trials free?
Yes, participation in raynaud phenomenon clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of raynaud phenomenon treatments are being studied?
Current raynaud phenomenon clinical trials are testing a range of approaches across NA (2 studies), PHASE4 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 5 research organizations.
Is it safe to participate in raynaud phenomenon clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov